| Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities B Razani, TP Combs, XB Wang, PG Frank, DS Park, RG Russell, M Li, ... Journal of Biological Chemistry 277 (10), 8635-8647, 2002 | 711 | 2002 |
| Caveolin, caveolae, and endothelial cell function PG Frank, SE Woodman, DS Park, MP Lisanti Arteriosclerosis, thrombosis, and vascular biology 23 (7), 1161-1168, 2003 | 475 | 2003 |
| The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin E Chorin, M Dai, E Shulman, L Wadhwani, R Bar-Cohen, C Barbhaiya, ... Nature medicine 26 (6), 808-809, 2020 | 468 | 2020 |
| Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo W Schubert, PG Frank, B Razani, DS Park, CW Chow, MP Lisanti Journal of Biological Chemistry 276 (52), 48619-48622, 2001 | 417 | 2001 |
| Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade SE Woodman, DS Park, AW Cohen, MWC Cheung, M Chandra, J Shirani, ... Journal of Biological Chemistry 277 (41), 38988-38997, 2002 | 335 | 2002 |
| QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin E Chorin, L Wadhwani, S Magnani, M Dai, E Shulman, ... Heart rhythm 17 (9), 1425-1433, 2020 | 318 | 2020 |
| Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts AW Cohen, DS Park, SE Woodman, TM Williams, M Chandra, J Shirani, ... American Journal of Physiology-Cell Physiology 284 (2), C457-C474, 2003 | 296 | 2003 |
| Genetic ablation of caveolin-1 confers protection against atherosclerosis PG Frank, H Lee, DS Park, NN Tandon, PE Scherer, MP Lisanti Arteriosclerosis, thrombosis, and vascular biology 24 (1), 98-105, 2004 | 281 | 2004 |
| Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype DS Park, SE Woodman, W Schubert, AW Cohen, PG Frank, M Chandra, ... The American journal of pathology 160 (6), 2207-2217, 2002 | 273 | 2002 |
| Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (−/−) null mice show … H Lee, DS Park, B Razani, RG Russell, RG Pestell, MP Lisanti The American journal of pathology 161 (4), 1357-1369, 2002 | 255 | 2002 |
| Caveolin-1 expression enhances endothelial capillary tubule formation J Liu, XB Wang, DS Park, MP Lisanti Journal of Biological Chemistry 277 (12), 10661-10668, 2002 | 237 | 2002 |
| Caveolin-1 and regulation of cellular cholesterol homeostasis PG Frank, MWC Cheung, S Pavlides, G Llaverias, DS Park, MP Lisanti American Journal of Physiology-Heart and Circulatory Physiology 291 (2 …, 2006 | 196 | 2006 |
| Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice TM Williams, MWC Cheung, DS Park, B Razani, AW Cohen, WJ Muller, ... Molecular biology of the cell 14 (3), 1027-1042, 2003 | 196 | 2003 |
| Caveolin-1 null (−/−) mice show dramatic reductions in life span DS Park, AW Cohen, PG Frank, B Razani, H Lee, TM Williams, ... Biochemistry 42 (51), 15124-15131, 2003 | 188 | 2003 |
| Myocardial infarction accelerates breast cancer via innate immune reprogramming GJ Koelwyn, AAC Newman, MS Afonso, C van Solingen, EM Corr, ... Nature medicine 26 (9), 1452-1458, 2020 | 175 | 2020 |
| Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins G Bonuccelli, F Sotgia, W Schubert, DS Park, PG Frank, SE Woodman, ... The American journal of pathology 163 (4), 1663-1675, 2003 | 155 | 2003 |
| The cardiac conduction system DS Park, GI Fishman Circulation 123 (8), 904-915, 2011 | 154 | 2011 |
| The cardiac conduction system DS Park, GI Fishman Circulation 123 (8), 904-915, 2011 | 154 | 2011 |
| Effect of obstructive sleep apnea treatment on atrial fibrillation recurrence: a meta-analysis A Shukla, A Aizer, D Holmes, S Fowler, DS Park, S Bernstein, N Bernstein, ... JACC: Clinical Electrophysiology 1 (1), 41-51, 2015 | 146 | 2015 |
| Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis LS Danielson, DS Park, N Rotllan, A Chamorro-Jorganes, MV Guijarro, ... The FASEB Journal 27 (4), 1460, 2013 | 140 | 2013 |
